sr 33557 has been researched along with cholecalciferol in 1 studies
| Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
|---|---|---|---|---|---|
| 50 | 3 | 1 | 8,234 | 1,425 | 3,471 |
| Protein | Taxonomy | sr 33557 (IC50) | cholecalciferol (IC50) |
|---|---|---|---|
| Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Feys, G; Laruel, A; Manning, AS; Mouton, J | 1 |
1 other study(ies) available for sr 33557 and cholecalciferol
| Article | Year |
|---|---|
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Calcinosis; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Cholecalciferol; Dose-Response Relationship, Drug; Indoles; Indolizines; Male; Mesenteric Arteries; Myocardium; Phenethylamines; Rats; Rats, Sprague-Dawley; Staining and Labeling; Sulfones; Verapamil | 1995 |